“…In dealing with mechanistic complexity and underlying uncertainty, a computational toxicologist can integrate explicit modeling of “known” events with statistical methods (assuming a large and chemically diverse dataset) and/or nonspecific reactivity approaches. , In our previous work, we have shown that robust toxicological models can be developed using the modular CADRE (computer-aided discovery and REdesign) platform. , CADRE relies on a tiered approach to bioavailability, metabolic activation, and covalent haptenation of biological targets by integrating an expert system with molecular simulations and QM calculations (Figure ). Because uncertainty is of concern even for the well-characterized toxicity pathways (e.g., dermal sensitization), CADRE balances site-specific QM calculations of known transformations with descriptors derived from frontier molecular orbital (FMO) theory, which captures the reactivity broadly. , Paired with transparent LDA and multivariate linear regression (MLR) modeling, this strategy has delivered robust predictions across multiple toxic endpoints and a diverse chemical space. ,− In particular, CADRE has outperformed other tools when considering larger, heavily functionalized, and biologically active APIs and synthetic intermediates. , …”